Aterian (NASDAQ:ATER) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Aterian (NASDAQ:ATER) from a hold rating to a sell rating in a research report sent to investors on Saturday.

Separately, Weiss Ratings raised shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Aterian has a consensus rating of “Sell”.

Aterian Trading Down 10.1%

ATER stock opened at $0.36 on Friday. Aterian has a 1-year low of $0.35 and a 1-year high of $1.87. The business’s 50 day simple moving average is $1.16 and its 200 day simple moving average is $0.88. The firm has a market capitalization of $3.92 million, a PE ratio of -0.14 and a beta of 0.68.

Aterian (NASDAQ:ATER) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $0.30. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The business had revenue of $0.02 million during the quarter, compared to the consensus estimate of $15.82 million.

Hedge Funds Weigh In On Aterian

A number of large investors have recently made changes to their positions in ATER. Goldman Sachs Group Inc. lifted its holdings in Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after purchasing an additional 9,026 shares during the last quarter. XTX Topco Ltd acquired a new position in Aterian in the 2nd quarter valued at $55,000. Citadel Advisors LLC increased its position in Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after buying an additional 22,865 shares during the period. Finally, Susquehanna International Group LLP increased its position in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after buying an additional 30,637 shares during the period. Institutional investors own 7.02% of the company’s stock.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.